Brief: Valeo Pharma Reports Its Second Quarter 2022 Results And Highlights
14/06/2022 23:07
June 14 (Reuters) - Valeo Pharma Inc VPH.TO :
* VALEO PHARMA REPORTS ITS SECOND QUARTER 2022 RESULTS AND
HIGHLIGHTS
* VALEO PHARMA INC - Q2-22 REVENUES OF $4.8 MILLION COMPARED
TO
$2.6 MILLION FOR Q2-21, UP 80%
* VALEO PHARMA INC - NET LOSS OF $5.1 MILLION FOR Q2-22
COMPARED
TO $1.9 MILLION FOR Q2-21
Source text for Eikon: ID:nCNWW2YkTa
Further company coverage: VPH.TO
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada